Abstract

Histone post-translational modifications (PTMs) play a critical role in chromatin regulation. It has been proposed that these PTMs form localized 'codes' that are read by specialized regions (reader domains) in chromatin associated proteins (CAPs) to regulate downstream function. Substantial effort has been made to define [CAP : histone PTM] specificities, and thus decipher the histone code and guide epigenetic therapies. However, this has largely been done using the reductive approach of isolated reader domains and histone peptides, which cannot account for any higher order factors. Here we show that the [BPTF PHD finger and bromodomain : histone PTM] interaction is dependent on nucleosome context. The tandem reader selectively associates with nucleosomal H3K4me3 and H3K14ac or H3K18ac, a combinatorial engagement that despite being in cis is not predicted by peptides. This in vitro specificity of the BPTF tandem reader for PTM-defined nucleosomes is recapitulated in a cellular context. We propose that regulatable histone tail accessibility and its impact on the binding potential of reader domains necessitates we refine the 'histone code' concept and interrogate it at the nucleosome level.

Data availability

Raw data from dCypher assays is in Supplementary File 1. All sequencing data has been deposited in the NCBU Gene Expression Omnibus (GEO) with accession number GSE150617.

The following data sets were generated

Article and author information

Author details

  1. Matthew R Marunde

    EpiCypher, Durham, United States
    Competing interests
    Matthew R Marunde, MRM is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  2. Harrison A Fuchs

    Department of Biochemistry, University of Colorado Anschutz Medical Campus, Aurora, United States
    Competing interests
    No competing interests declared.
  3. Jonathan M Burg

    EpiCypher, Durham, United States
    Competing interests
    Jonathan M Burg, JB is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  4. Irina K Popova

    EpiCypher, Durham, United States
    Competing interests
    Irina K Popova, IKP is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  5. Anup Vaidya

    EpiCypher, Durham, United States
    Competing interests
    Anup Vaidya, AV is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  6. Nathan W Hall

    EpiCypher, Durham, United States
    Competing interests
    Nathan W Hall, NWH is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  7. Ellen N Weinzapfel

    EpiCypher, Durham, United States
    Competing interests
    Ellen N Weinzapfel, ENW is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  8. Matthew J Meiners

    EpiCypher, Durham, United States
    Competing interests
    Matthew J Meiners, MJM is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  9. Rachel Watson

    EpiCypher, Durham, United States
    Competing interests
    Rachel Watson, RW is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  10. Zachary B Gillespie

    EpiCypher, Durham, United States
    Competing interests
    Zachary B Gillespie, ZBG is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  11. Hailey F Taylor

    EpiCypher, Durham, United States
    Competing interests
    Hailey F Taylor, HFT is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  12. Laylo Mukhsinova

    EpiCypher, Durham, United States
    Competing interests
    Laylo Mukhsinova, LM is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  13. Ugochi C Onuoha

    EpiCypher, Durham, United States
    Competing interests
    Ugochi C Onuoha, UCO is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  14. Sarah A Howard

    EpiCypher, Durham, United States
    Competing interests
    Sarah A Howard, SAH is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  15. Katherine Novitzky

    EpiCypher, Durham, United States
    Competing interests
    Katherine Novitzky, KN is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  16. Eileen T McAnarney

    EpiCypher, Durham, United States
    Competing interests
    Eileen T McAnarney, ETM is affiliated with EpiCypher Inc. The author has no financial interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2337-2889
  17. Krzysztof Krajewski

    Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    Krzysztof Krajewski, KK is affiliated with EpiCypher Inc. The author has no financial interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7159-617X
  18. Martis W Cowles

    EpiCypher, Durham, United States
    Competing interests
    Martis W Cowles, MWC is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  19. Marcus A Cheek

    EpiCypher, Durham, United States
    Competing interests
    Marcus A Cheek, MAC is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  20. Zu-Wen Sun

    EpiCypher, Durham, United States
    Competing interests
    Zu-Wen Sun, ZS is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  21. Bryan J Venters

    EpiCypher, Durham, United States
    Competing interests
    Bryan J Venters, BJV is affiliated with EpiCypher Inc. The author has no financial interests to declare..
  22. Michael-C Keogh

    EpiCypher, Durham, United States
    For correspondence
    mkeogh@epicypher.com
    Competing interests
    Michael-C Keogh, MCK is a board member of EpiCypher Inc. The author has no financial interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2219-8623
  23. Catherine A Musselman

    Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, United States
    For correspondence
    catherine.musselman@cuanschutz.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8356-7971

Funding

National Institutes of Health (2T32GM008365-26A1)

  • Harrison A Fuchs

National Institutes of Health (P30CA086862)

  • Catherine A Musselman

National Science Foundation (CAREER-1452411)

  • Harrison A Fuchs

National Institutes of Health (R35GM128705)

  • Harrison A Fuchs
  • Catherine A Musselman

National Institutes of Health (R43CA236474)

  • Matthew R Marunde
  • Jonathan M Burg
  • Irina K Popova
  • Anup Vaidya
  • Nathan W Hall
  • Ellen N Weinzapfel
  • Matthew J Meiners
  • Rachel Watson
  • Zachary B Gillespie
  • Hailey F Taylor
  • Laylo Mukhsinova
  • Ugochi C Onuoha
  • Sarah A Howard
  • Katherine Novitzky
  • Eileen T McAnarney
  • Krzysztof Krajewski
  • Martis W Cowles
  • Marcus A Cheek
  • Zu-Wen Sun
  • Bryan J Venters
  • Michael-C Keogh

National Institutes of Health (R44GM117683)

  • Matthew R Marunde
  • Jonathan M Burg
  • Irina K Popova
  • Anup Vaidya
  • Nathan W Hall
  • Ellen N Weinzapfel
  • Matthew J Meiners
  • Rachel Watson
  • Zachary B Gillespie
  • Hailey F Taylor
  • Laylo Mukhsinova
  • Ugochi C Onuoha
  • Sarah A Howard
  • Katherine Novitzky
  • Eileen T McAnarney
  • Krzysztof Krajewski
  • Martis W Cowles
  • Marcus A Cheek
  • Zu-Wen Sun
  • Bryan J Venters
  • Michael-C Keogh

National Institutes of Health (R44CA214076)

  • Matthew R Marunde
  • Jonathan M Burg
  • Irina K Popova
  • Anup Vaidya
  • Nathan W Hall
  • Ellen N Weinzapfel
  • Matthew J Meiners
  • Rachel Watson
  • Zachary B Gillespie
  • Hailey F Taylor
  • Laylo Mukhsinova
  • Ugochi C Onuoha
  • Sarah A Howard
  • Katherine Novitzky
  • Eileen T McAnarney
  • Krzysztof Krajewski
  • Martis W Cowles
  • Marcus A Cheek
  • Zu-Wen Sun
  • Bryan J Venters
  • Michael-C Keogh

National Institutes of Health (R44GM116584)

  • Matthew R Marunde
  • Jonathan M Burg
  • Irina K Popova
  • Anup Vaidya
  • Nathan W Hall
  • Ellen N Weinzapfel
  • Matthew J Meiners
  • Rachel Watson
  • Zachary B Gillespie
  • Hailey F Taylor
  • Laylo Mukhsinova
  • Ugochi C Onuoha
  • Sarah A Howard
  • Katherine Novitzky
  • Eileen T McAnarney
  • Krzysztof Krajewski
  • Martis W Cowles
  • Marcus A Cheek
  • Zu-Wen Sun
  • Bryan J Venters
  • Michael-C Keogh

National Institutes of Health (R44DE029633)

  • Matthew R Marunde
  • Jonathan M Burg
  • Irina K Popova
  • Anup Vaidya
  • Nathan W Hall
  • Ellen N Weinzapfel
  • Matthew J Meiners
  • Rachel Watson
  • Zachary B Gillespie
  • Hailey F Taylor
  • Laylo Mukhsinova
  • Ugochi C Onuoha
  • Sarah A Howard
  • Katherine Novitzky
  • Eileen T McAnarney
  • Krzysztof Krajewski
  • Martis W Cowles
  • Marcus A Cheek
  • Zu-Wen Sun
  • Bryan J Venters
  • Michael-C Keogh

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2024, Marunde et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,871
    views
  • 341
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Matthew R Marunde
  2. Harrison A Fuchs
  3. Jonathan M Burg
  4. Irina K Popova
  5. Anup Vaidya
  6. Nathan W Hall
  7. Ellen N Weinzapfel
  8. Matthew J Meiners
  9. Rachel Watson
  10. Zachary B Gillespie
  11. Hailey F Taylor
  12. Laylo Mukhsinova
  13. Ugochi C Onuoha
  14. Sarah A Howard
  15. Katherine Novitzky
  16. Eileen T McAnarney
  17. Krzysztof Krajewski
  18. Martis W Cowles
  19. Marcus A Cheek
  20. Zu-Wen Sun
  21. Bryan J Venters
  22. Michael-C Keogh
  23. Catherine A Musselman
(2024)
Nucleosome conformation dictates the histone code
eLife 13:e78866.
https://doi.org/10.7554/eLife.78866

Share this article

https://doi.org/10.7554/eLife.78866

Further reading

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Ananda Kishore Mukherjee, Subhajit Dutta ... Shantanu Chowdhury
    Research Article

    Telomeres are crucial for cancer progression. Immune signalling in the tumour microenvironment has been shown to be very important in cancer prognosis. However, the mechanisms by which telomeres might affect tumour immune response remain poorly understood. Here, we observed that interleukin-1 signalling is telomere-length dependent in cancer cells. Mechanistically, non-telomeric TRF2 (telomeric repeat binding factor 2) binding at the IL-1-receptor type-1 (IL1R1) promoter was found to be affected by telomere length. Enhanced TRF2 binding at the IL1R1 promoter in cells with short telomeres directly recruited the histone-acetyl-transferase (HAT) p300, and consequent H3K27 acetylation activated IL1R1. This altered NF-kappa B signalling and affected downstream cytokines like IL6, IL8, and TNF. Further, IL1R1 expression was telomere-sensitive in triple-negative breast cancer (TNBC) clinical samples. Infiltration of tumour-associated macrophages (TAM) was also sensitive to the length of tumour cell telomeres and highly correlated with IL1R1 expression. The use of both IL1 Receptor antagonist (IL1RA) and IL1R1 targeting ligands could abrogate M2 macrophage infiltration in TNBC tumour organoids. In summary, using TNBC cancer tissue (>90 patients), tumour-derived organoids, cancer cells, and xenograft tumours with either long or short telomeres, we uncovered a heretofore undeciphered function of telomeres in modulating IL1 signalling and tumour immunity.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bethany M Bartlett, Yatendra Kumar ... Wendy A Bickmore
    Research Article Updated

    During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.